XML 42 R31.htm IDEA: XBRL DOCUMENT v3.21.2
10. Segment Information Segment Reporting (Tables)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2021
Segment Reporting [Abstract]    
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Information regarding operating segments for the three months ended June 30, 2021 and 2020 is as follows (in millions):
Life
Science
Clinical
Diagnostics
Other
Operations
Segment net sales 2021$334.2 $380.2 $1.5 
 2020$252.1 $283.2 $1.6 
Segment net profit (loss)2021$64.6 $60.1 $(0.3)
 2020$35.4 $10.5 $0.1 
Information regarding operating segments for the six months ended June 30, 2021 and 2020 is as follows (in millions):
Life
Science
Clinical
Diagnostics
Other
Operations
Segment net sales 2021$700.7 $738.8 $3.2 
 2020$479.2 $623.4 $5.9 
Segment net profit (loss)2021$166.9 $58.2 $(0.2)
 2020$59.1 $54.3 $1.2 
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]   The following reconciles total segment profit to consolidated income before income taxes (in millions):
Three Months EndedSix Months Ended
June 30,June 30,
 2021202020212020
Total segment profit $124.4 $46.0 $224.9 $114.6 
Foreign currency exchange gains (losses), net1.8 (0.8)1.7 (1.7)
Change in fair market value of equity securities1,030.7 1,183.5 2,210.1 2,011.2 
Other (expense) income, net(0.1)17.2 17.3 20.5 
Consolidated income before income taxes$1,156.8 $1,245.9 $2,454.0 $2,144.6